BridgeMD
New treatment option for Composite Resins
Official title Clinical Evaluation of Color-Adjusting Composite Resin Following In-Office Dental Bleaching
ClinicalTrials.gov ID: NCT06884813
What this study is testing
What is Conventional nanohybrid multishade composite and hydrogen peroxide 40% in-Office Tooth Whitening System?
Conventional nanohybrid multishade composite and hydrogen peroxide 40% in-Office Tooth Whitening System is an investigational medicine, being studied as a potential treatment for composite resins.
Also referred to as Conventional resin based composite (RBC) and Hydrogen perioxide 40%.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- One challenge faced by dental professionals is that, unlike natural tooth structure, composite restorations do not lighten when exposed to bleaching agents. As a result, functional restorations may need replacement after bleaching to match the newly whitened teeth.
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Patients who are willing to come back for follow-up appointments.
- Patients who are willing to sign an informed consent form.
- Patients with well documented clinical records and have at least two anterior restorations (both Omnichroma and conventional multi-shade nanohybrid...
- Patients aged 18 years or older.
- Patients with good oral hygiene
You likely can't join if
- Individuals with severe bruxism or periodontal disease.
- Patients with non-vital teeth restored with composite fillings.
- Patients with severe tooth discoloration.
- Patients with fluorosis or tetracycline staining.
- Heavy smokers.
- Pregnant or nursing women.
See the full eligibility criteria
- Patients who are willing to come back for follow-up appointments.
- Patients who are willing to sign an informed consent form.
- Patients with well documented clinical records and have at least two anterior restorations (both Omnichroma and conventional multi-shade nanohybrid composite.)
- Patients aged 18 years or older.
- Patients with good oral hygiene
- Patients with vital teeth.
- Patients who are willing to have the restorations replaced later if necessary if there is a color mismatch after bleaching treatment.
- Individuals with severe bruxism or periodontal disease.
- Patients with non-vital teeth restored with composite fillings.
- Patients with severe tooth discoloration.
- Patients with fluorosis or tetracycline staining.
- Heavy smokers.
- Pregnant or nursing women.
- Patients undergoing orthodontic treatment.
- Patients with enamel or dentin deformations.
The study team makes the final eligibility decision.
Where it's taking place
- Irbid, Jordan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Irbid, Jordan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.